Lung Cancer

Lung cancer is a disease in which the cells of the lung tissues grow uncontrollably and form tumors. There are two kinds of lung cancers, primary and secondary. Primary lung cancer (also called adenocarcinoma) starts in the lung itself. Primary lung cancer is divided into small cell lung cancer and non-small cell lung cancer, depending on how the cells look under the microscope. Secondary lung cancer is cancer that starts somewhere else in the body (for example, the breast or colon) and spreads to the lungs.

Lung Cancer - most related articles:

- Quitting smoking doubles survival in lung cancer patients - 5
- Urine test predicts lung cancer risk in smokers - 4.8
- Lilly's lung cancer drug Alimta is approved in US - 4.8
- Green tea may reduce lung cancer risk in smokers - 4.6
- Fir tree found in man's lung - 4.5
- PET imaging more accurate in lung cancer staging - 4.5
- Surgery remans an option for lung cancer patients - 4.4
- Racial differences in lung cancer beliefs - 4.3
- 20% reduction in lung cancer mortality with low dose CT vs chest X ray - 4.2
- Gene expression changes in nasal cells may help identify lung cancer - 4.2

Lung Cancer articles

Postoperative radiotherapy does not improve survival in lung cancer patients
Post-operative radiation therapy (PORT), a controversial yet frequently administered treatment for lung cancer, may not prolong life in older people with locally advanced disease.

New lung cancer test could accurately guide treatment for people with lung cancer
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.

20% reduction in lung cancer mortality with low dose CT vs chest X ray
Scientists have found a 20 percent reduction in deaths from lung cancer among current or former heavy smokers who were screened with low-dose helical computed tomography (CT) versus those screened by chest X-ray. The primary research results from the National Lung Screening Trial (NLST) were published in the New England Journal of Medicine.

Gene expression changes in nasal cells may help identify lung cancer
A simple, minimally-invasive technique using cells from the interior of the nose could help clinicians detect lung cancer in its earliest - and most treatable - stages, according to a study conducted by researchers in Boston.

Genetic test for lung cancer risk prompts smokers to quit
New research shows a gene-based test for lung cancer risk assessment motivates smokers to quit or cut down, according to results of a clinical study presented today at the American Association of Cancer Research's Ninth Annual Conference on Frontiers in Cancer Prevention Research.

Cancer deaths continue to drop in US
The continued drop in overall cancer mortality rates over the last 20 years has averted more than three-quarters of a million (767,000) cancer deaths according to a new report from the American Cancer Society.

Vitamin B6 lowers risk of lung cancer
An analysis that included nearly 400,000 participants finds that those with higher blood levels of vitamin B6 and the essential amino acid methionine (found in most protein) had an associated lower risk of lung cancer, including participants who were current or former smokers.

Shark cartilage drug AE-941 does not improve lung cancer survival
The anti-cancer drug AE-941, a shark cartilage derivative, did not improve overall survival in patients with inoperable stage III non-small cell lung cancer, according to a study published online May_26 in the Journal of the National Cancer Institute.

Gene biomarker to identify smokers for lung cancer risk
Researchers from Boston University School of Medicine (BUSM) in collaboration with investigators at the University of Utah, have discovered a new approach for identifying smokers at the highest risk for developing lung cancer.

Racial differences in lung cancer beliefs
A new survey finds that while both whites and African Americans know and think little about lung cancer, African Americans are more likely to hold beliefs and perceptions about the disease that could interfere with prevention and treatment.

Quitting smoking doubles survival in lung cancer patients
People diagnosed with early stage lung cancer can double their chances of survival over five years if they stop smoking compared with those who continue to smoke.

Green tea may reduce lung cancer risk in smokers
Drinking green tea could modulate the effect of smoking on lung cancer. Results of this hospital-based, randomized study conducted in Taiwan were presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held here from Jan_11-14, 2010.

Pistachios may reduce lung cancer risk
A diet that incorporates a daily dose of pistachios may help reduce the risk of lung and other cancers, according to data presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference.

Secondhand smoke exposure increases lung cancer risk
Children exposed to secondhand cigarette smoke have an increased risk of developing lung cancer in adulthood, even if they never smoked.

Few questions can determine risk for lung cancer
Aa simple questionnaire designed to identify patients at high risk of lung cancer is found helpful. The new study is featured in the November issue of the Journal of Thoracic Oncology.

Public smoking bans reduce heart attacks
Public smoking bans appear to significantly reduce the risk of heart attacks, particularly among younger individuals and nonsmokers, revealed by researchers in a new study.

Surgery remans an option for lung cancer patients
Surgery after standard chemotherapy and radiation can be an option for lung cancer patients, revealed by researchers in new study published in the Lancet.

Thalidomide does not improve survival in lung cancer
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, revealed by researchers.

Lilly's lung cancer drug Alimta is approved in US
Eli Lilly's lung cancer drug Alimta (pemetrexed) -- the first drug available for maintenance therapy of advanced or metastatic lung cancer, is approved by the U.S. Food and Drug Administration, USA.

Cancer - a concern in schizophrenia patients
Schizophrenia patients are four times as likely to die from all causes and are 50 percent more likely to die from cancer compared to people in the general population, revealed by researchers.

Vandetanib with docetaxel improve lung cancer survival
When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas M. D. Anderson Cancer Center.

Stem cell clue to lung cancer development
Cancer Research UK scientists have revealed that stem cells become 'activated' in severely damaged lungs and help to repair them, according to a study published in the Proceeding of the National Academy of Sciences.

GenWay Biotech distributor of AMDL's DR-70 cancer test in US and Canada
GenWay Biotech, Inc., a US-based diagnostic company which specializes in providing protein and antibody solutions, announced its partnership with AMDL, Inc., a US-based pharmaceutical company with major operations in China, regarding the distribution of AMDL's DR-70 (FDP) cancer test in both the United States and Canada.

New early detection studies of lung cancer in nonsmokers
Government and private sector cancer scientists today launched a research partnership to find biomarkers for lung cancer that develops in people who have never smoked.

Urine test predicts lung cancer risk in smokers
Researchers may have uncovered why lung cancer afflicts some smokers and not others, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.

Fir tree found in man's lung
A 5 cm fir tree has been found in the lung tissue of a 28 year old russian man who complained of pain in his chest.

Smoking linked with most male cancers
The association between tobacco smoke and cancer deaths - beyond lung cancer deaths - has been strengthened by a recent study from a UC Davis researcher, suggesting that increased tobacco control efforts could save more lives than previously estimated.

Lung cancer mortality may be reduced by better policies to control indoor radon
About 1100 people each year die in the UK from lung cancer related to indoor radon, but current government protection policies focus mainly on the small number of homes with high radon levels and neglect the 95% of radon related deaths caused by lower levels of radon, according to a study published on bmj.com today.

Few DNA repair genes associated with cancer risk
Variants of numerous DNA repair genes initially appeared to be statistically significantly associated with cancer risk in epidemiological studies.

Food additives linked to lung cancer risk
New research in an animal model suggests that a diet high in inorganic phosphates, which are found in a variety of processed foods including meats, cheeses, beverages, and bakery products, might speed growth of lung cancer tumors and may even contribute to the development of those tumors in individuals predisposed to the disease.

Mesothelioma compensation right defended by Unite the union
In a landmark test case in the High Court, Unite the union, has successfully defended the rights of vulnerable asbestos victims from insurers' attempts to avoid their liabilities.

New genes identified linked to lung cancer
Working as part of a multi-institutional collaboration, scientists at Washington University School of Medicine in St. Louis have assembled the most complete catalog to date of the genetic changes underlying the most common form of lung cancer.

Indoor pollution in homes in China causing respiratory diseases
If current levels of smoking and biomass and coal fuel use in homes continues, between 2003 and 2033 there will be an estimated 65 million deaths from chronic obstructive pulmonary disease (COPD) and 18 million deaths from lung cancer in China, accounting for 19% and 5% of all deaths in that country during this period.

Eli Lilly's Alimta approvad for lung cancer
Eli Lilly and Company (NYSE: LLY) announced that it received approval from the U.S. Food and Drug Administration (FDA) for the use of ALIMTA(R) (pemetrexed for injection), in combination with cisplatin, in the first-line treatment of locally-advanced and metastatic non-small cell lung cancer (NSCLC), for patients with nonsquamous histology.

Physicians rarely show empathy with lung cancer patients
In consultations with patients with lung cancer, physicians rarely responded empathically to the concerns of the patients about mortality, symptoms or treatment options, according to a study led by a University of Rochester Medical Center researcher.

Lung cancer among lifelong nonsmokers
A new American Cancer Society study sheds light on the ten to fifteen percent of lung cancers that are caused by factors other than tobacco smoking. The study analyzed data on lung cancer occurrence among lifelong nonsmokers in North America, Europe, and Asia and found that lung cancer death rates among never-smokers are highest among men, African Americans, and Asians residing in Asia.

Melanoma skin cancer rising in Victoria
New figures from The Cancer Council Victoria show that the number of Victorians affected by melanoma is at the highest level ever. Latest figures from the Victorian Cancer Registry show that in 2005, melanoma overtook lung cancer and is now the fourth most common cause of cancer in Victorians.

Vitamin supplements may increase lung cancer risk
Vitamin supplements do not protect against lung cancer, according to a study of more than 77,000 vitamin users. In fact, some supplements may even increase the risk of developing it. The findings were published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

Bowel cancer rising in Australia, reports AIHW
A new Australian report released by the Australian Institute of Health and Welfare (AIHW) presents a mixed bag on favourable and unfavourable trends in chronic diseases over time. The report, Indicators for chronic disease and their determinants, 2008, focuses on the 12 chronic conditions that represent a large burden of disease in Australia.

Anemia drugs for cancer patients raises blood clots risk
Treating anemia with a class of drugs known as erythropoiesis-stimulating agents (ESAs) is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs) and death among patients with cancer, according to an article in the February 27 issue of JAMA.

Gene changes after smoking affects lung cancer
Smoking plays a role in lung cancer development, and now scientists have shown that smoking also affects the way genes are expressed, leading to alterations in cell division and regulation of immune response. Notably, some of the changes in gene expression persisted in people who had quit smoking many years earlier.

Lung cancer cells' survival gene 14-3-3zeta seen as drug target
One of the deadliest forms of cancer appears to carry a specific weakness. When a key gene called 14-3-3zeta is silenced, lung cancer cells can't survive on their own, researchers have found.

Quit Smoking – a Healthy Start to 2008
The Australian Medical Association AMA is urging all smokers to put their health first in 2008 by making a New Year's resolution to quit smoking for good.

PET imaging more accurate in lung cancer staging
Positron emission tomography (PET) is a useful diagnostic tool that supports the need for more accurate staging of lung cancer and improved treatment for patients, concludes an extensive systematic review published online in Journal of National Cancer Institute.

44 Lung Cancer articles listed above.

Subscribe to Health News by Email






What is Lung Cancer
Lung cancer is a disease in which the cells of the lung tissues grow uncontrollably and form tumors. There are two kinds of lung cancers, primary and secondary. Primary lung cancer (also called adenocarcinoma) starts in the lung itself. Primary lung cancer is divided into small cell lung cancer and non-small cell lung cancer, depending on how the cells look under the microscope. Secondary lung cancer is cancer that starts somewhere else in the body (for example, the breast or colon) and spreads to the lungs.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
0.61